Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: A randomized clinical trial

Canadian Journal of Veterinary Research

Volumn 78, Issue 1, 2014, Pages 31-37

  Truchetti, Geoffrey ^a   Bouchard, Émile ^a   DesCôteaux, Luc ^a   Scholl, Daniel ^b   Roy, Jean Philippe ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTIOFUR; SPECTRAMAST; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DAIRY CATTLE; DISEASE SEVERITY; DRUG EFFICACY; FOLLOW UP; INCIDENCE; MASTITIS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; BACTERIA; BACTERIAL INFECTIONS; BOVINAE; CLASSIFICATION; DRUG ADMINISTRATION; FEMALE; MASTITIS, BOVINE; MICROBIOLOGY; VETERINARY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CATTLE; CEPHALOSPORINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; MASTITIS, BOVINE;

EID: 84892496572     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Erskine RJ, Wagner S, DeGraves FJ. Mastitis therapy and pharmacology. Vet Clin North Am Food Anim Pract 2003;19:109-138
2. Sargeant JM, Scott HM, Leslie KE, Ireland MJ, Bashiri A. Clinical mastitis in dairy cattle in Ontario: Frequency of occurrence and bacteriological isolates. Can Vet J 1998;39:33-38.
3. DeGraves FJ, Fetrow J. Economics of mastitis and mastitis control. Vet Clin North Am Food Anim Pract 1993;9:421-434.
4. Hogeveen H, Huijps K, Lam TJ. Economic aspects of mastitis: New developments. N Z Vet J 2011;59:16-23.
5. Deluyker HA, Michaenek P, Wuyts N, VanOye SN, Chester ST. We Treat Sick Cows Don't We? The Case of Subclinical Mastitis. National Mastitis Council Annual Meeting Proceedings 2001: 170-174.
6. Gillespie BE, Moorehead H, Lunn P, et al. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp. and Staphylococcus aureus intramammary infections in lactating dairy cows. Vet Ther 2002;3:373-380.
7. Taponen S, Dredge K, Henriksson B, et al. Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin G plus neomycin in bovine clinical mastitis caused by penicillinsusceptible, Gram-positive bacteria - A double blind field study. J Vet Pharmacol Ther 2003;26:193-198.
8. Oliver SP, Gillespie BE, Headrick SJ, et al. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows. J Dairy Sci 2004;87:2393-2400.
9. Hillerton JE, Kliem KE. Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J Dairy Sci 2002;85:1009-1014.
10. Oliver SP, Almeida RA, Gillespie BE, et al. Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle. J Dairy Sci 2004;87: 3322-3329.
11. Oliver SP, Almeida RA, Gillespie BE, et al. Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle. Vet Ther 2003;4:299-308.
12. Hornish RE, Kotarski SF. Cephalosporins in veterinary medicine-ceftiofur use in food animals. Curr Top Med Chem 2002; 2:717-731.
13. Roberson JR. Establishing treatment protocols for clinical mastitis. Vet Clin North Am Food Anim Pract 2003;19:223-234
14. National Mastitis Council. Laboratory and Field Handbook on Bovine Mastitis. 1st ed. Arlington, Virginia: Natl. Mastitis Counc, 1987.
15. Cattel MB. An outbreak of Streptococci uberis as a consequence of adopting a protocol of no antibiotic therapy for clinical mastitis. Proceeding of the 35th National Mastitis Council Annual Meeting 1996:123.
16. Dopfer D, Barkema HW, Lam TJ, Schukken YH, Gaastra W. Recurrent clinical mastitis caused by Escherichia coli in dairy cows. J Dairy Sci 1999;82:80-85.
17. Morin DE, Shanks RD, McCoy GC. Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis. J Am Vet Med Assoc 1998;213:676-684.
18. Olde Riekerink RG, Barkema HW, Kelton DF, Scholl DT. Incidence rate of clinical mastitis on canadian dairy farms. J Dairy Sci 2008;91:1366-1377.
19. Middleton JR, Luby CD. Escherichia coli mastitis in cattle being treated for Staphylococcus aureus intramammary infection. Vet Rec 2008;162:156-157.
20. Roy JP, DesCoteaux L, DuTremblay D, Beaudry F, Elsener J. Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus. Can Vet J 2009;50:1257-1262.
21. Deluyker HA, Oye SNV, Boucher JF. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci 2005;88:604-614.
22. Bishop H, Erkelens J, Van Winden S. Predictors for successful bacteriological culture from milk samples. Vet Rec 2010;166: 322-324.
23. Bradley AJ, Leach KA, Breen JE, Green LE, Green MJ. Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales. Vet Rec 2007;160:253-257.
24. Ferguson JD, Azzaro G, Gambina M, Licitra G. Prevalence of mastitis pathogens in Ragusa, Sicily, from 2000 to 2006. J Dairy Sci 2007;90:5798-5813.
25. Reyher KK, Dufour S, Barkema HW, et al. The National Cohort of Dairy Farms - A data collection platform for mastitis research in Canada. J Dairy Sci 2010;94:1616-1626.